Abstract
Preliminary Review on the Patentability of the New Drugs and Vaccine, Patent Prosecution and Infringement Disputes under the Global COVID-19 Epidemic (II)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have